Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Create safe, inclusive choir spaces for transgender singers with supportive language and programming.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The conclusion is that sex-verification in sports was harmful and changes have been made to address this.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Transgender women can still get testicular cancer, so proper screening is important.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Gender affirmation surgery improves personal appearance and self-esteem.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.